Is the price fair?
What BLCO's price assumes
Bausch + Lomb Corporation did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 1.08× revenue.
1.08
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.89
Price / book · as of 2026-Q1
- EV / sales
- 2.00
EV / sales
Details›
- Price / book2026-Q1
- 0.89
- EV / EBIT2026-Q1
- 45.5
- EV / sales2026-Q1
- 2.00
- Market capitalisation
- $5.30B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #7 of 27 by Smart Score